Dynamic Technology Lab Private LTD Athenex, Inc. Transaction History

Dynamic Technology Lab Private LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.97 - $4.84 $58,111 - $94,699	-19,566 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$3.71 - $5.13 $72,589 - $100,373	19,566 New	19,566 $91,000
Q1 2021 May 14, 2021	SELL	$4.08 - $14.75 $193,090 - $698,058	-47,326 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$11.06 - $14.01 $523,425 - $663,037	47,326 New	47,326 $523,000
Q2 2020 Aug 14, 2020	SELL	$7.11 - $13.76 $328,083 - $634,941	-46,144 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$5.71 - $15.85 $263,482 - $731,382	46,144 New	46,144 $357,000
Q4 2019 Feb 14, 2020	SELL	$9.6 - $17.75 $110,966 - $205,172	-11,559 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$12.16 - $21.0 $140,557 - $242,739	11,559 New	11,559 $141,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.